Showing results (31-40 of 168) with videos related to

Sort By:
Pageof 17
Nature|July 29, 2026
New-deal mortgage programmes benefited white borrowers disproportionatelyKatherine A Thomas, Thomas B Storrs, Wenfei Xu, et al.
Yeast (Chichester, England)|February 1, 1995
Development and application of an in vivo system to study yeast ribosomal RNA biogenesis and functionJ Venema, A Dirks-Mulder, A W Faber, et al.
Expert Review of Vaccines|December 12, 2017
EDiP: the Epitope Dilution Phenomenon. Lessons learnt from a malaria vaccine antigen and its applicability to polymorphic antigensKwadwo Asamoah Kusi, Bart W Faber, Gerrit Koopman, et al.
Plos One|August 23, 2012
Posttraumatic stress symptoms after exposure to two fire disasters: comparative studyNancy E Van Loey, Rens van de Schoot, Albertus W Faber
Biochemical and Biophysical Research Communications|March 27, 1996
Androgen regulation of the rat keratinocyte growth factor (KGF/FGF7) promoterC Fasciana, A C van der Made, P W Faber, et al.
Foot & Ankle International|January 11, 2002
Mobility of the first tarsometatarsal joint in hallux valgus patients: a radiographic analysisF W Faber, G J Kleinrensink, P G Mulder, et al.
RNA (New York, N.Y.)|October 3, 2002
Ngl2p is a Ccr4p-like RNA nuclease essential for the final step in 3'-end processing of 5.8S rRNA in Saccharomyces cerevisiaeAlex W Faber, Marie Van Dijk, Hendrik A Raué, et al.
BMC Immunology|August 1, 2019
Identification of adjuvants for clinical trials performed with Plasmodium falciparum AMA1 in rabbitsSumera Younis, Bart W Faber, Clemens H M Kocken, et al.
Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery|January 1, 1987
Psychological and social problems in burn patients after discharge. A follow-up studyA W Faber, H J Klasen, E W Sauër, et al.
Vaccine|March 22, 2020
E. coli production process yields stable dengue 1 virus-sized particles (VSPs)Janet Hirsch, Bart W Faber, James E Crowe, et al.
Pageof 17